http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015025440-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b74c69588b99b41cf96112bd0febd968 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0648 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-013 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0079 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate | 2014-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ddde9b4ce8f91bbae39280c7e3703e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a46da3d55fa73cae6b23c82c6c23ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9a4288208869acb3784dd6265c90652 |
| publicationDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2015025440-A1 |
| titleOfInvention | Eye Therapy System |
| abstract | Embodiments apply a cross-linking agent to a region of corneal tissue. The cross-linking agent improves the ability of the corneal tissue to resist undesired structural changes. For example, the cross-linking agent may be Riboflavin or Rose Bengal, and the initiating element may be photoactivating light, such as ultraviolet (UV) light. In these embodiments, the photoactivating light initiates cross-linking activity by irradiating the applied cross-linking agent to release reactive oxygen radicals in the corneal tissue. The cross-linking agent acts as a sensitizer to convert O 2 into singlet oxygen which causes cross-linking within the corneal tissue. The rate of cross-linking in the cornea is related to the concentration of O 2 present when the cross-linking agent is irradiated with photoactivating light. Accordingly, the embodiments control the concentration of O 2 during irradiation to increase or decrease the rate of cross-linking and achieve a desired amount of cross-linking. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017147926-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10932864-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013593-B2 |
| priorityDate | 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.